The Novel Aspirin as Breakthrough Drug for COVID-19: A Narrative Review
Introduction: Aspirin has justifiably been called the first miracle drug. In this article, we highlight the history of Aspirin, a novel mechanism of action, and its use in cardiovascular and other diseases. Also included is a brief statement of emerging new applications. Objective: We highlight pri...
Guardado en:
Autores principales: | Bamidele Johnson Alegbeleye, Oke-Oghene Philomena Akpoveso, Adewale James Alegbeleye, Rana Kadhim Mohammed, Eduardo Esteban-Zubero |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Emergency Department of Hospital San Pedro (Logroño, Spain)
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9498a08eaf7d46e89ea721b6111bea8b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hazardous Effect of Low-Dose Aspirin in Patients with Predialysis Advanced Chronic Kidney Disease Assessed by Machine Learning Method Feature Selection
por: Ming-Hsien Tsai, et al.
Publicado: (2021) -
Automedicación en individuos de la Región de la Araucanía con problemas musculoesqueléticos
por: Riedemann G,J Pablo, et al.
Publicado: (2001) -
Not all (N)SAID and done: Effects of nonsteroidal anti‐inflammatory drugs and paracetamol intake on platelets
por: Ben Driver, et al.
Publicado: (2020) -
Concomitant Administration of Alprazolam and Ibuprofen in Acute Migraine Headache
por: M Baradaran, et al.
Publicado: (2011) -
Enfermedad de Still del adulto: Una gran simuladora. Experiencia clínica basada en 20 casos
por: Carreño,M Ángela, et al.
Publicado: (2009)